The downregulation of p62 along with fewer expressions of LC3-II, an active form of LC3, and lysosomal enzymes, such as cathepsin D, suggests that autophagy has been activated in CM-treated CNS following stroke due to the elimination of autophagosomes by lysosomes (Klionsky et al., 2016). This evidence concerns the gene MAP1LC3A and stroke disorder.